SCHEMBL24145178

SCHEMBL24145178

CC(=O)O[C@@H]1O[C@H](C(=O)N2CCN(c3ccccc3Cl)CC2)[C@@H](OC(C)O)[C@H](OC(C)=O)[C@H]1OC(C)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ AKR1C3 P42330 1/20 0.42
▸ GAA P10253 2/20 0.42
▸ USP2 O75604 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ LIPE Q05469 1/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ POLB P06746 1/20 0.39
▸ TSHR P16473 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MAPT P10636 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ GRM5 P41594 1/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ HTR7 P34969 1/20 0.36
▸ GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21112925 0.92 GAA (0.47) SMN1; SMN2AKR1C3GAAUSP2LMNA
SCHEMBL24145067 0.89 ALDH1A1 (0.48) AKR1C3GAALMNAMAPK1MEN1
SCHEMBL24145052 0.87 TFPI2 (0.42) SMN1; SMN2AKR1C3LMNAMAPK1MEN1
SCHEMBL24145051 0.85 MEN1 (0.45) SMN1; SMN2AKR1C3USP2LMNAMEN1
SCHEMBL24145064 0.81 SMN1; SMN2 (0.47) SMN1; SMN2AKR1C3GAAMAPK1KMT2A
SCHEMBL24145057 0.80 TP53 (0.43) SMN1; SMN2GAAMAPK1LIPEMEN1
SCHEMBL21112883 0.80 ALDH1A1 (0.53) SMN1; SMN2AKR1C3LMNAMAPK1MEN1
SCHEMBL20873345 0.78 TFPI2 (0.47) SMN1; SMN2AKR1C3USP2LMNAMEN1
SCHEMBL20873315 0.77 MEN1 (0.50) SMN1; SMN2AKR1C3LMNAMAPK1MEN1
SCHEMBL24145085 0.75 HRH3 (0.41) POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210401946-A1 CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-12-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210401946-A1 CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 SMN1; SMN2 4049/4885AKR1C3 1463/4885GAA 143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback